SUFFRITTI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 3.176
EU - Europa 2.626
AS - Asia 2.461
SA - Sud America 278
AF - Africa 65
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.622
Nazione #
US - Stati Uniti d'America 3.073
CN - Cina 935
GB - Regno Unito 718
SG - Singapore 688
IT - Italia 507
DE - Germania 253
HK - Hong Kong 228
SE - Svezia 199
BR - Brasile 195
RU - Federazione Russa 195
FR - Francia 148
VN - Vietnam 142
IN - India 114
NL - Olanda 114
IE - Irlanda 87
FI - Finlandia 81
TR - Turchia 72
CA - Canada 65
ES - Italia 65
JP - Giappone 60
UA - Ucraina 50
KR - Corea 47
DK - Danimarca 42
ID - Indonesia 39
AR - Argentina 33
CI - Costa d'Avorio 30
MX - Messico 25
PL - Polonia 23
AT - Austria 21
BE - Belgio 20
PT - Portogallo 20
UZ - Uzbekistan 17
BD - Bangladesh 16
CH - Svizzera 16
CO - Colombia 16
EU - Europa 15
AE - Emirati Arabi Uniti 13
TH - Thailandia 13
AU - Australia 11
CL - Cile 10
CZ - Repubblica Ceca 10
HU - Ungheria 10
IR - Iran 10
PH - Filippine 10
PE - Perù 9
PK - Pakistan 9
TW - Taiwan 9
ZA - Sudafrica 9
BG - Bulgaria 8
IQ - Iraq 7
MA - Marocco 7
SA - Arabia Saudita 7
RO - Romania 6
EC - Ecuador 5
GR - Grecia 5
HR - Croazia 5
NP - Nepal 5
VE - Venezuela 5
AL - Albania 4
DZ - Algeria 4
EG - Egitto 4
IL - Israele 4
JM - Giamaica 4
KE - Kenya 4
RS - Serbia 4
LT - Lituania 3
LV - Lettonia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
JO - Giordania 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
NO - Norvegia 2
PA - Panama 2
SC - Seychelles 2
SI - Slovenia 2
UY - Uruguay 2
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MQ - Martinica 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
TT - Trinidad e Tobago 1
Totale 8.635
Città #
Southend 608
Singapore 411
Ashburn 326
Chandler 251
Milan 224
Dallas 214
Hong Kong 198
Beijing 159
San Jose 145
Fairfield 121
Wilmington 108
Los Angeles 97
New York 94
Houston 93
Ann Arbor 86
Council Bluffs 84
Dublin 75
Seattle 73
Princeton 71
Frankfurt am Main 65
Redwood City 58
Woodbridge 56
Santa Clara 55
Helsinki 54
Dearborn 52
Hefei 46
Lauterbourg 45
Ho Chi Minh City 43
Munich 41
Hanoi 40
Tokyo 40
Bengaluru 39
Nanjing 39
Cambridge 37
Shanghai 35
Boardman 34
Buffalo 34
Putian 34
Des Moines 31
Guangzhou 31
Abidjan 30
Jinan 30
Jakarta 29
Moscow 28
Mountain View 27
Barcelona 24
Istanbul 24
Mumbai 23
Fuzhou 22
Jacksonville 22
Toronto 22
Chicago 21
Columbus 21
Phoenix 19
São Paulo 19
Redmond 18
Seoul 18
Brussels 17
Shenyang 16
Changsha 15
Hangzhou 15
London 15
Nanchang 15
Tianjin 15
Berlin 14
Buenos Aires 14
Fremont 14
Rio de Janeiro 14
San Diego 14
Zhengzhou 14
Cangzhou 13
Denver 13
Orem 13
Ottawa 13
Somerville 13
Duncan 12
Lisbon 12
Serra 12
Chennai 11
Roxbury 11
Warsaw 11
Amsterdam 10
Bogotá 10
Haiphong 10
Napoli 10
Nuremberg 10
Rome 10
The Dalles 10
Vienna 10
Xiamen 10
Andover 9
Atlanta 9
Boston 9
Montreal 9
Shenzhen 9
Stockholm 9
Tashkent 9
Budapest 8
Jiaxing 8
Madrid 8
Totale 5.247
Nome #
Current and emerging biologics for the treatment of hereditary angioedema 752
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency 342
Remittent C1-inhibitor deficiency due to Arg378Cys mutation 332
A transcriptomics study of hereditary angioedema attacks 332
Intermittent C1-Inhibitor Deficiency Associated with Recessive Inheritance: Functional and Structural Insight 316
Marcatori di severità di malattia nei soggetti con angioedema da carenza C1 inibitore. 296
Gene regulation in the pathogenesis of angioedema due to inherited c1 inhibitor deficiency (hereditary angioedema) 279
Structural and functional characterization of mutations in C1-ihn responsible for hereditary angioedema 263
Molecular mechanism for the pathogenicity of the human C1-inhibitor Arg378Cys variant 257
Hereditary angioedema: Assessing the hypothesis for underlying autonomic dysfunction 250
Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema : functional and structural correlates 241
A SERPING1 variant that causes C1-inhibitor deficiency without hereditary angioedema 221
Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency 220
Identification of variables causing different clinical expression of inherited c1-inh deficiency (hereditary angioedema) 217
Efficacy of on-demand treatment in reducing morbidity in patients with hereditary angioedema due to C1 inhibitor deficiency 211
Ongoing contact activation in patients with hereditary angioedema 209
Immune response covaries with corticosterone plasma levels under experimentally stressful conditions in nestling barn swallows (Hirundo rustica) 204
Patterns of C1-Inhibitor Plasma Levels and Kinin–Kallikrein System Activation in Relation to COVID-19 Severity 183
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients 182
Optimizing long-term joint health in the treatment of hemophilia 179
A case of remittent C1-inhibitor deficiency 177
Complement and contact system activation in acute congestive heart failure patients 175
C1 esterase inhibitor and the kinin-kallikrein system in COVID-19 174
Two Cases Of Peculiar Hypereosinophilic Syndrome Treated With Mepolizumab 173
Catabolism of C1 inhibitor influences the response to replacement therapy in hereditary angioedema 172
Anti-C1-Inhibitor Autoantibody Detection by ELISA 170
Lung Ultrasound Findings and Endothelial Perturbation in a COVID-19 Low-Intensity Care Unit 169
Novelties in the diagnosis and treatment of angioedema 165
Secreted phospholipases A2 in hereditary angioedema with C1-inhibitor deficiency 163
Hereditary angioedema due to C1 inhibitor deficiency in Belarus : epidemiology, access to diagnosis and seven novel mutations in SERPING1 gene 160
Updates on Novel Non-Replacement Drugs for Hemophilia 154
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor 132
Exploring the prevalence and clinical impact of fibromyalgia syndrome in patients with shoulder diseases: a cross-sectional study 122
Real-Life Experience With Subcutaneous Plasma-Derived C1-Inhibitor for Long-Term Prophylaxis in Patients With Hereditary Angioedema: A Case Series 119
Efficacy of Lanadelumab in angioedema due to acquired C1 inhibitor deficiency 119
Pathophysiology of hereditary angioedema 118
Structural and functional characterization of mutations in C1-inh responsible for hereditary angioedema 116
Hereditary Deficiency of C1 Inhibitor and Angioedema 115
Cleaved kininogen as a biomarker for bradykinin release in hereditary angioedema 113
Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency : clinical and molecular characterization 103
High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin mediated angioedema due to hereditary c1-inhibitor deficiency 99
Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study 96
Elevated plasma levels of vascular permeability factors in C1 inhibitor-deficient hereditary angioedema 90
Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations 67
Measurement of cleaved high-molecular-weight kininogen in patients with hereditary angioedema due to C1-inhibitor deficiency: preanalytical and analytical optimization 47
Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients 40
Quantitative multiplex profiling of the complement system to diagnose complement‐mediated diseases 38
Artificial Intelligence for Automated Detection of Joint Bleeding via Ultrasound in Hemophilia: Advancing Standardization 36
Platelet function abnormalities in acquired hemophilia A 31
Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key? 29
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor 28
Totale 8.996
Categoria #
all - tutte 24.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.483


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021197 0 0 0 0 0 0 0 0 0 64 102 31
2021/2022612 42 30 31 34 41 28 38 47 117 53 29 122
2022/2023786 89 91 78 101 68 130 18 55 92 12 45 7
2023/2024543 19 51 36 35 143 81 16 33 20 19 41 49
2024/20251.433 47 109 21 122 81 79 52 131 157 193 178 263
2025/20262.773 298 220 397 276 316 204 437 104 304 217 0 0
Totale 8.996